Organization
Sorriso Pharmaceuticals
1 clinical trial
Clinical trial
A Ph I Randomized Double-Blind First-in-Human Single Ascending Dose & Multiple Dose Study to Investigate the Safety Tolerability and Pharmacokinetics of SOR102 in Healthy Adult Participants and Patient Volunteers With Mild to Severe Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2024-12-01